Compare CRVS & LEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRVS | LEG |
|---|---|---|
| Founded | 2014 | 1883 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2016 | 2018 |
| Metric | CRVS | LEG |
|---|---|---|
| Price | $14.31 | $9.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | ★ $30.17 | $10.50 |
| AVG Volume (30 Days) | 771.2K | ★ 1.8M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.85% |
| EPS Growth | 48.04 | ★ 145.31 |
| EPS | N/A | ★ 0.47 |
| Revenue | N/A | ★ $5,203,900,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.73 |
| P/E Ratio | ★ N/A | $20.02 |
| Revenue Growth | N/A | ★ 1.37 |
| 52 Week Low | $5.29 | $8.34 |
| 52 Week High | $26.95 | $13.00 |
| Indicator | CRVS | LEG |
|---|---|---|
| Relative Strength Index (RSI) | 49.46 | 38.66 |
| Support Level | $14.24 | $8.57 |
| Resistance Level | $16.66 | $11.45 |
| Average True Range (ATR) | 0.72 | 0.27 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 50.00 | 5.00 |
Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.
Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the maximum of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.